| P2093 | author name string | Zhimin Li | |
| | Jing Cai | |
| | Jing Wang | |
| | Lan Xiao | |
| | Zehua Wang | |
| | Lili Yu | |
| | Sha Hu | |
| P2860 | cites work | MicroRNAs and cancer: profile, profile, profile | Q37039839 |
| | Inhibition of microRNA with antisense oligonucleotides | Q37044780 |
| | MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells | Q37199087 |
| | Role of microRNA in anticancer drug resistance | Q37563160 |
| | Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis. | Q39898008 |
| | Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells | Q39932777 |
| | Role of microRNAs in drug-resistant ovarian cancer cells | Q39934697 |
| | Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2. | Q39958914 |
| | Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells | Q39994304 |
| | MicroRNAs as oncogenes and tumor suppressors | Q81406722 |
| | Carcinoma of the Ovary | Q95826402 |
| | Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth | Q24319862 |
| | Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells | Q24647234 |
| | miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates | Q24647285 |
| | Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? | Q27860893 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 | Q28210189 |
| | miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 |
| | Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 |
| | A brain-specific microRNA regulates dendritic spine development | Q29614753 |
| | miR-21-mediated tumor growth | Q29616149 |
| | MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN | Q29616575 |
| | Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results | Q33332312 |
| | MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells | Q33497932 |
| | Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. | Q34108288 |
| | The Role of ABC Transporters in Clinical Practice | Q34268081 |
| | Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. | Q34798833 |
| | A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer | Q34985302 |
| | Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective. | Q36297321 |
| | The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research | Q36365560 |
| | Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents | Q36893330 |
| | OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 125-130 | |
| P577 | publication date | 2010-07-10 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells | |
| P478 | volume | 119 | |